High-activity mutants of butyrylcholinesterase for cocaine hydrolysis and method of generating the same
US-9206403-B1 · Dec 8, 2015 · US
US11773383B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11773383-B2 |
| Application number | US-202117349933-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 17, 2021 |
| Priority date | Nov 3, 2020 |
| Publication date | Oct 3, 2023 |
| Grant date | Oct 3, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed is a method for promoting extracellular expression of proteins in B. subtilis using cutinase, which belongs to the technical fields of genetic engineering, enzyme engineering and microbial engineering. It teaches co-expressing a cutinase mutant and a target protein in B. subtilis to promote extracellular expression of the target protein which is naturally located inside cells. The target protein includes xylose isomerase, 4,6-α-glucosyltransferase, 4-α-glucosyltransferase, trehalose synthase, branching enzyme and the like. The invention can achieve extracellular expression of intracellularly localized target protein, improve the production efficiency, reduce the production cost and simplify the subsequent extraction process.
Opening claim text (preview).
What is claimed is: 1. A cutinase mutant, which is a cutinase having the amino acid sequence of SEQ ID NO: 1 except having I213A and P214A substitutions. 2. A method for extracellularly producing an exogenous protein, comprising: a) inoculating a recombinant B. subtilis coexpressing the cutinase mutant of claim 1 and an exogenous intracellularly located protein into a seed medium to obtain a seed liquid; b) inoculating the seed liquid into a fermentation medium for performing fermentation to obtain a fermentation broth; and c) centrifuging the fermentation broth and obtaining the exogenous protein in the fermentation supernatant of the centrifuged fermentation broth. 3. The method of claim 2 , wherein the recombinant B. subtilis are inoculated into the seed medium and cultured at 35-38° C., 180-220 rpm for 8-10 hours to obtain the seed liquid, and the seed liquid is inoculated into the fermentation medium and cultured at 30-37° C., 180-220 rpm for 20-26 hours. 4. The method of claim 2 , wherein the seed medium comprises 8-12 g/L peptone, 4-6 g/L yeast extract and 8-12 g/L sodium chloride. 5. The method of claim 2 , wherein the fermentation medium comprises 20-25 g/L yeast extract, 5-10 g/L soy peptone and 4-6 g/L glycerol, and the initial pH of the fermentation medium is 6-7.
Carboxylic ester hydrolases {(3.1.1)} · CPC title
Hexosyltransferases (2.4.1) · CPC title
Glucose isomerase {(5.3.1.5; 5.3.1.9; 5.3.1.18)} · CPC title
for Bacillus · CPC title
Alpha,alpha-trehalose synthase (2.4.1.245) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.